Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial.

van den Bergh MR, Spijkerman J, Swinnen KM, Fran├žois NA, Pascal TG, Borys D, Schuerman L, Ijzerman EP, Bruin JP, van der Ende A, Veenhoven RH, Sanders EA.

Clin Infect Dis. 2013 Feb;56(3):e30-9. doi: 10.1093/cid/cis922. Epub 2012 Nov 1.

2.

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

Prymula R, Schuerman L.

Expert Rev Vaccines. 2009 Nov;8(11):1479-500. doi: 10.1586/erv.09.113. Review.

PMID:
19863240
3.

10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.

Plosker GL.

Paediatr Drugs. 2014 Oct;16(5):425-44. doi: 10.1007/s40272-014-0089-x. Review.

PMID:
25192686
4.

Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Croxtall JD, Keating GM.

Paediatr Drugs. 2009;11(5):349-57. doi: 10.2165/11202760-000000000-00000. Review.

PMID:
19725600
5.

The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.

Nicholls TR, Leach AJ, Morris PS.

Vaccine. 2016 Feb 3;34(6):703-13. doi: 10.1016/j.vaccine.2015.12.048. Epub 2015 Dec 29. Review.

6.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
7.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
8.

Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.

Khan MN, Ren D, Kaur R, Basha S, Zagursky R, Pichichero ME.

Expert Rev Vaccines. 2016 Jul;15(7):863-78. doi: 10.1586/14760584.2016.1156539. Epub 2016 Mar 17. Review.

PMID:
26894630
9.

Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Silfverdal SA, Coremans V, Fran├žois N, Borys D, Cleerbout J.

Expert Rev Vaccines. 2017 Feb;16(2):109-121. doi: 10.1586/14760584.2016.1164044. Epub 2016 Sep 30. Review.

PMID:
26954689
10.

Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.

Duell BL, Su YC, Riesbeck K.

FEBS Lett. 2016 Nov;590(21):3840-3853. doi: 10.1002/1873-3468.12351. Epub 2016 Aug 25. Review.

PMID:
27508518
11.

Panel 6: Vaccines.

Pettigrew MM, Alderson MR, Bakaletz LO, Barenkamp SJ, Hakansson AP, Mason KM, Nokso-Koivisto J, Patel J, Pelton SI, Murphy TF.

Otolaryngol Head Neck Surg. 2017 Apr;156(4_suppl):S76-S87. doi: 10.1177/0194599816632178. Review.

12.

Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.

Murphy TF.

Clin Vaccine Immunol. 2015 May;22(5):459-66. doi: 10.1128/CVI.00089-15. Epub 2015 Mar 18. Review.

13.

Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies.

Bergenfelz C, Hakansson AP.

Curr Otorhinolaryngol Rep. 2017;5(2):115-124. doi: 10.1007/s40136-017-0152-6. Epub 2017 May 20. Review.

14.

Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review

Behrouzi A, Vaziri F, Rahimi-Jamnani F, Afrough P, Rahbar M, Satarian F, Siadat SD.

Iran Biomed J. 2017 Mar;21(2):69-76. Review.

15.

Co-infection subverts mucosal immunity in the upper respiratory tract.

Lijek RS, Weiser JN.

Curr Opin Immunol. 2012 Aug;24(4):417-23. doi: 10.1016/j.coi.2012.05.005. Epub 2012 Jun 2. Review.

16.

Potential impact of a Moraxella catarrhalis vaccine in COPD.

Perez AC, Murphy TF.

Vaccine. 2017 Feb 6. pii: S0264-410X(16)31300-7. doi: 10.1016/j.vaccine.2016.12.066. [Epub ahead of print] Review.

PMID:
28185742

Supplemental Content

Support Center